Clinical Trial Update: ENERGI-F701 for Female Hair Loss Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ENERGI-F701 targeting female hair loss and pattern baldness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Female Pattern Hair Loss
• Hair Loss

Drugs mentioned

• ENERGI-F701

Snippet

Sponsor: Energenesis Biomedical Co., Ltd. | Conditions: Female Pattern Baldness, Hair Loss | Phase 2 | Status: COMPLETED